Bio-Techne Corp (TECH)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $11.44B
Last updated: Nov 17, 2026 at 11:06 AM ET
Bio-Techne Corp (TECH) P/E Ratio & Valuation History
Bio-Techne (TECH) trades at 39.6x trailing earnings and 9.3x sales. Its P/E of 39.6x is above its 5-year median of 39.2x. Its forward P/E is 35.7x. The median P/E across 5 similar companies is 40.4x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 10.9% higher over the next year. Its free cash flow yield is 2.7%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 39.6x |
| Forward P/E | 35.7x |
| Price to sales | 9.3x |
| Price to book | 5.3x |
| EV/EBITDA | 33.4x |
| Price to FCF | 37.0x |
| EV/FCF | 36.5x |
| PEG | 2.2 |
| FCF yield | 2.7% |
Historical Medians
Against its 10-year medians, its P/E is 1.0% below 40.0x, its P/S is 13.4% above 8.2x and its P/B is 3.6% below 5.5x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 39.6x | 39.2x | 40.0x |
| P/S | 9.3x | 10.0x | 8.2x |
| P/B | 5.3x | 5.6x | 5.5x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 28.9x in 2016 to 69.9x in 2021.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $58.81 | 30.8x | 7.6x | 4.6x |
| 2024 | $72.03 | 39.8x | 9.6x | 5.5x |
| 2023 | $77.16 | 40.8x | 10.7x | 6.2x |
| 2022 | $82.88 | 42.1x | 11.7x | 7.1x |
| 2021 | $129.34 | 69.9x | 19.9x | 11.9x |
| 2020 | $79.39 | 57.9x | 15.4x | 8.1x |
| 2019 | $54.88 | 47.7x | 4.6x | 1.8x |
| 2018 | $36.18 | 31.2x | 2.5x | 1.2x |
| 2017 | $32.39 | 32.4x | 4.7x | 4.9x |
| 2016 | $25.71 | 28.9x | 4.2x | 1.1x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About TECH
What is TECH's forward P/E ratio?
Bio-Techne has a forward P/E ratio of 35.7x.
Is TECH stock overvalued?
GNG's valuation label for TECH is Undervalued. Its P/E of 39.6x compares with a median of 40.4x across 5 similar companies.
What is TECH's price to sales ratio?
Bio-Techne has a price to sales ratio of 9.3x.
What is Bio-Techne's average P/E ratio over 5 years?
Bio-Techne's median P/E over the last 5 years is 39.2x, from 60 month-end values through Oct 2026.
What is TECH's PEG ratio?
Bio-Techne has a PEG ratio of 2.2.
TECH pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors